Underlying mechanisms of novel cuproptosis-related dihydrolipoamide branched-chain transacylase E2 (DBT) signature in sunitinib-resistant clear-cell renal cell carcinoma

Shiue-Wei Lai; Pei-Wei Weng; Vijesh Kumar Yadav; Narpati Wesa Pikatan; Chi-Tai Yeh; Ming-Shou Hsieh; Chu-Lin Chou

doi:doi:10.18632/aging.205504

← Back

Research Paper Volume 16, Issue 3 pp 2679—2701

Underlying mechanisms of novel cuproptosis-related dihydrolipoamide branched-chain transacylase E2 (DBT) signature in sunitinib-resistant clear-cell renal cell carcinoma

Figure 1. Differential expression of cuproptosis-related genes (CRGs) in ccRCC cohorts. (A) Heatmap and (B) Volcano plot of the differential expression of CRGs in normal tissues in ccRCC cohort GSE40435 (n = 202).